NCT07304011
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07304011
Title Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of California, Davis
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Jonsson Comprehensive Cancer Center NOT_YET_RECRUITING Los Angeles California 90024 United States Details
UCI Health Chao Family Comprehensive Cancer Center RECRUITING Orange California 92868 United States Details
University of California Davis Comprehensive Cancer Center RECRUITING Sacramento California 95817 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field